Grant: Discovery Grants Program - Individual
University of Toronto
$28,000.00
The Microbial Battlefield: Streptomyces Anti-Phage Chemical Warfare
FY 2020-21
Summary
This grant will investigate the production of anti-phage secondary metabolites by Streptomyces bacteria. Phages are viruses that infect and kill bacteria. They are the most abundant biological entity on earth, outnumbering bacteria by a factor of ten. It is estimated that Avogadro's number of phage infections occurs each second on earth. This pervasive selection pressure combined with the ubiquity of phages in the environment has led to the evolution of a wide array of bacterial anti-phage defense mechanisms. For example, bacteria can inhibit phage attachment at the cell surface, block genome replication, or degrade the phage genome using restriction enzymes or the CRISPR-Cas system. Given the intensity of the bacteria-phage arms race, it is highly probable that other defense mechanisms remain to be delineated. Characterization of these mechanisms will provide important insight into how phage-host interactions shape the microbial world.
Previous studies searching for compounds that inhibit E. coli phage replication identified a number of secondary metabolites produced by different species of Streptomyces that actively block phage propagation. The high frequency with which we identified these secondary metabolites among Streptomyces strains led us to hypothesize that secondary metabolites provide a previously uncharacterized anti-phage defense system. In this proposal, we will determine if Streptomyces use secondary metabolites as an endogenous anti-phage defense mechanism and will identify genetic pathways through which these molecules are synthesized. We have developed a unique platform for pursuing these studies that combines high-throughput screening with detailed biochemical and genetic studies that will allow us to identify molecules and directly link them with anti-phage activities. This work will ascribe biological functions to previously uncharacterized secondary metabolites and provide new insight into the evolutionary arms race between bacteria and phages, which plays important roles in nutrient cycling, global climate, biodiversity, and species distribution.
Program
Discovery Grants Program - Individual
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data
As published
Application id
RGPIN-2017-06898
Name nom
Maxwell, Karen
Department département
Biochemistry
Organization id
31
Institution établissement
University of Toronto
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2020
Competition year année de concours
2017
Award amount
28000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
1501
Committee name en
Genes, Cells and Molecules
Committee name fr
Gènes, cellules et molécules
Area of application code
1201
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Life sciences (including biotechnology)
Area of application fr
Sciences de la vie (y compris biotechnologie)
Research subject code
5201
Research subject group en
Microbiology
Research subject group fr
Microbiologie
Research subject en
Bacteriology
Research subject fr
Bactériologie
Installment
inst:4-5
Partie
2
Nb partie
5
Application title
The Microbial Battlefield: Streptomyces Anti-Phage Chemical Warfare
Keyword
NSERC
Application summary
This grant will investigate the production of anti-phage secondary metabolites by Streptomyces bacteria. Phages are viruses that infect and kill bacteria. They are the most abundant biological entity on earth, outnumbering bacteria by a factor of ten. It is estimated that Avogadro's number of phage infections occurs each second on earth. This pervasive selection pressure combined with the ubiquity of phages in the environment has led to the evolution of a wide array of bacterial anti-phage defense mechanisms. For example, bacteria can inhibit phage attachment at the cell surface, block genome replication, or degrade the phage genome using restriction enzymes or the CRISPR-Cas system. Given the intensity of the bacteria-phage arms race, it is highly probable that other defense mechanisms remain to be delineated. Characterization of these mechanisms will provide important insight into how phage-host interactions shape the microbial world.
Previous studies searching for compounds that inhibit E. coli phage replication identified a number of secondary metabolites produced by different species of Streptomyces that actively block phage propagation. The high frequency with which we identified these secondary metabolites among Streptomyces strains led us to hypothesize that secondary metabolites provide a previously uncharacterized anti-phage defense system. In this proposal, we will determine if Streptomyces use secondary metabolites as an endogenous anti-phage defense mechanism and will identify genetic pathways through which these molecules are synthesized. We have developed a unique platform for pursuing these studies that combines high-throughput screening with detailed biochemical and genetic studies that will allow us to identify molecules and directly link them with anti-phage activities. This work will ascribe biological functions to previously uncharacterized secondary metabolites and provide new insight into the evolutionary arms race between bacteria and phages, which plays important roles in nutrient cycling, global climate, biodiversity, and species distribution.